Enhanced lung fibrosis in protein C inhibitor transgenic mice

E. C. Gabazza, Y. Nishii, H. Nakahara, H. Fujimoto, H. Kobayashi, H. Yasui, C. N. D‘Alessandro-Gabazza, T. Hayashi, K. Suzuki, O. Taguchi (Tsu, Japan)

Source: Annual Congress 2004 - Pulmonary fibrosis - new insights
Session: Pulmonary fibrosis - new insights
Session type: Oral Presentation
Number: 3020
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. C. Gabazza, Y. Nishii, H. Nakahara, H. Fujimoto, H. Kobayashi, H. Yasui, C. N. D‘Alessandro-Gabazza, T. Hayashi, K. Suzuki, O. Taguchi (Tsu, Japan). Enhanced lung fibrosis in protein C inhibitor transgenic mice. Eur Respir J 2004; 24: Suppl. 48, 3020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Vascular remodeling in the lung from mice treated with monocrotaline. The effect of protein C inhibitor transgenic expression
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006

Increased susceptibility to gammaherpesvirus-induced lung fibrosis of transgenic mice with conditional overexpression of the ER-stress-factor Chop in alveolar epithelium
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019

Alveolar type 2 cell dysfunction from expression of a surfactant protein C (SFTPC) mutation drives a fibrotic lung phenotype in mice
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017

Tenascin C knockout mice have an altered lung function at newborn and adult age
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017

TGF-beta-dependent inhibitor of DNA protein (Id) expression in lung fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 521s
Year: 2006

Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


Transgenic mice expressing a surfactant protein-B-urokinase-fusion protein in the distal respiratory epithelium show an attenuated fibrotic response to bleomycin-induced lung injury
Source: Annual Congress 2005 - In vivo - approaches to lung injury
Year: 2005


High proteasome activity and absence of NF-kB activation in cystic fibrosis cell culture and CF KO mouse models in response to oxidative stress
Source: Eur Respir J 2005; 26: Suppl. 49, 403s
Year: 2005

Surface enolase-1 mediated cell migration and lung fibrosis in bleomycin-induced mice
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021


Development of pulmonary fibrosis in conditional Nedd4-2 deficient mice
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018



A T cell-specific inhibitor of NF-kappaB and AP-1 suppresses lung fibrosis in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 101s
Year: 2004

Alteration of eicosanoid metabolism/signalling in IL-9 overexpressing mice and impact on lung fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 575s
Year: 2007

Enhancement of bleomycin-induced lung fibrosis in tenascin C-deficient mice
Source: Eur Respir J 2004; 24: Suppl. 48, 103s
Year: 2004

Aged tenascin-C knockout mice have increased lung volume and septal surface but unchanged lung function
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018



Inhibition of napsin A induces proSP-B accumulation and ER-stress: a novel mouse model for lung fibrosis
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008

Heat shock protein 90 inhibitors block pulmonary fibrosis and dysfunction in HCl-exposed mice.
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017


Premature aging in Zmpste24 deficient mice protects them from bleomycin induced lung fibrosis through upregulation of antifibrotic microRNAs
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018

The effect of bleomycin on the lungs of TGFβ1 transgenic mice
Source: Eur Respir J 2001; 18: Suppl. 33, 80s
Year: 2001

Expression of the nuclear factor-?B inhibitor A20 is altered in the cystic fibrosis epithelium
Source: Eur Respir J 2013; 41: 1315-1323
Year: 2013



Late Breaking Abstract - B cells are not involved in the regulation of adenoviral TGF-ß1- or bleomycin-induced lung fibrosis in mice
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021